Colita ulceroasă nespecifică prin etiopatogeneza neclară, caracterul empiric al farmacoterapiei bolii cu eşecuri multiple, particularităţile evolutive cu transcendenţă frecventă în complicaţii grave, care impun operaţii seriate care cauzează invaliditate în rândul persoanelor tinere, apte de muncă, constituie o oportunitate a gastroenterologiei moderne. Evidenţa clinico-paraclinică de durată a pacienţilor, selecţia argumentată a timpului operator optim şi procedeului chirurgical, ne-a permis de a spori rata colectomiilor programate cu caracter reconstructiv primar până la 60.8%, de a reduce complicaţiile şi letalitatea postoperatorie după reconstrucţii până la 16.7% şi 3.6% respectiv. rezultatele postoperatorii la distanţă au fost urmărite la 26 (89.6%) din 29 pacienţi, care au suportat etapa reconstructivă. Termenii observaţiei au constituit 8 ani. Analizând rezultatele postoperatorii la distanţă, am ajuns la concluzia că ele sunt bune la 23 (58.9%) bolnavi, satisfăcătoare – la 11 (28.2%) bolnavi, nesatisfăcătoare – la 5 (12.9%) bolnavi.

Because of its unknown etiology and pathogenesis, empirical character of conservative therapy with multiple failures, evolutional peculiarities with transcendence in severe complications which require serial surgical interventions, followed by a high level of disability, ulcerative colitis became an advantage of modern gastroenterology. long time clinical and instrumental supervision of patients; scientifically motivate selection of the surgery time and the type of surgical intervention allowed us to increase the rate of programmed colectomies with primary reconstructive surgeries up to 60.8%, to reduce the frequency of postoperative complications and lethality after reconstructions down to 16.7% and 3.6% respectively. late postoperative results were recorded in 26 (89.6%) from 29 patients who underwent reconstructive surgery. The period of observation was of 10 years. We concluded that late postoperative results are good in 23 (58.9%) patients, satisfactory – in 11 (28.2%) patients, unsatisfactory – in 5 (12.9%) patients respectively.